Breaking news

Cyprus Sets Cap On Third-Country Students In Private Higher Education Institutions

In a significant policy shift, the Cypriot government has implemented a cap on the number of students from non-EU countries enrolled in private higher education institutions. This new regulation, ratified by the Cabinet, aims to strike a balance between attracting international talent and maintaining educational standards while ensuring adherence to national immigration policies. Effective from the academic year 2024-2025, the cap targets private institutions with high international-student ratios, reflecting Cyprus’ commitment to sustainable growth and quality education.

Rationale Behind the Cap

The decision to introduce this cap is multifaceted. Primarily, it aims to regulate the burgeoning number of international students to ensure that educational quality is not compromised. With a surge in third-country nationals seeking education in Cyprus, there has been growing concern about the capacity of private institutions to maintain high academic standards while accommodating an increasing number of students.

Furthermore, this policy addresses immigration control, ensuring that the influx of students aligns with the country’s broader immigration and demographic strategies. By managing the number of international students, the government aims to streamline the integration process and avoid potential socio-economic imbalances.

Implementation and Impact

The cap will be enforced starting from the 2024-2025 academic year, giving institutions time to adjust their admission processes and align with the new regulations. The Ministry of Education, Sports, and Youth, in collaboration with the Ministry of Interior, will oversee the implementation, ensuring compliance and providing support to institutions during the transition period.

Institutions with a high proportion of third-country students will need to reassess their recruitment strategies and may need to diversify their student base. This shift could lead to enhanced collaboration with EU countries and increased efforts to attract students from within the European Union.

Broader Implications for the Education Sector

This policy is expected to have several implications for the Cypriot education sector. For one, it may prompt private institutions to invest more in facilities, faculty, and resources to attract a diverse student body and maintain competitive standards. Additionally, the cap could encourage a more balanced distribution of international students across various institutions, promoting healthy competition and innovation in the education sector.

Moreover, the cap is part of Cyprus’s broader strategy to enhance the quality of higher education, making it a more attractive destination for high-calibre students globally. By ensuring that private institutions can offer top-notch education without being overwhelmed by numbers, Cyprus aims to solidify its reputation as a hub for quality higher education.

Cyprus’ MammoCheck Wins Top Honour At NBG Business Seeds Competition

Cyprus-based medical technology startup MammoCheck has won first place at the 16th NBG Business Seeds Innovation and Technology Competition, emerging as the overall winner from 344 entries submitted from Greece, Cyprus and other countries.

The annual competition, organised by the National Bank of Greece, announced the results during an awards ceremony in Athens. MammoCheck received the competition’s top distinction along with a €20,000 cash prize.

Founded in 2024 as a spin-out from Frederick University, MammoCheck is developing an artificial intelligence-powered Software as a Medical Device (SaMD) platform designed to support breast cancer screening. The solution combines a smartphone application with low-cost thermal cameras to provide an adjunctive screening tool powered by AI.

The company says its technology aims to address a significant gap in breast cancer screening, with hundreds of millions of women worldwide lacking regular access to mammography, including many women under the age of 45 who are not covered by most national screening programmes.

“We are honoured to receive first place among 344 entries from Greece, Cyprus and abroad. This recognition reflects the dedication of our team, our clinical partners and the women who inspire our work every day,”

said Alexandra Dimitriadou, co-founder and CEO of MammoCheck.

MammoCheck is currently conducting a clinical trial across multiple hospital sites as it advances toward FDA 510(k) clearance in the United States and CE marking under the European Union’s Medical Device Regulation (MDR).

The latest award marks another milestone for Cyprus’ growing health technology ecosystem, highlighting the increasing international visibility of locally developed medical innovations.

eCredo
The Future Forbes Realty Global Properties
Uol
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter